Compound and use thereof in the treatment of amyloidosis
US8236984B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2010 |
| Grant date | Aug 7, 2012 |
| Priority date | — |
| Expiry date | Oct 19, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) for stabilizing the tetrameric form of transthyretin, compounds for use in the treatment or prevention of amyloidosis, and agents and medicaments comprising such compounds.wherein X, Y, R1, R2, R3, R4, m, n, p, q, and the linker are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.